Potent inhibition of interleukin-6 expression in a human astrocytoma cell line by tenidap

Cell and Tissue Research

Volumn 288, Issue 2, 1997, Pages 251-257

  Lieb, Klaus ^a   Fiebich, Bernd L ^a   Hüll, Michael ^a   Berger, Mathias ^a   Bauer, Joachim ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Alzheimer's disease; Astrocytes; Cell culture; Human; Interleukin 1 ; Interleukin 6; Tenidap; Therapy

Indexed keywords

ANTIRHEUMATIC AGENT; INTERLEUKIN 6; TENIDAP;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTOMA CELL; HUMAN; HUMAN CELL; NERVE CELL CULTURE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASTROCYTES; ASTROCYTOMA; DRUG EVALUATION, PRECLINICAL; HUMANS; INDOLES; INTERLEUKIN-6; SECOND MESSENGER SYSTEMS; TUMOR CELLS, CULTURED;

EID: 0030951522     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004410050810     Document Type: Article

References (32)

1. 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52:487-501
2. Bauer J, Strauss S, Schreiter-Gasser U, Ganter U, Schlegel P, Witt I, Volk B, Berger M (1991a) Interleukin-6 and alpha2-macroglobulin indicate an acute-phase slate in Alzheimer's disease cortices. FEBS Lett 285:111-114
3. Bauer J, Strauss S, Volk B, Berger M (1991b) Interleukin-6-mediated events in Alzheimer's disease pathology. Immunol Today 12:422
4. Breedveld F (1994) Tenidap: a novel cytokine-modulating antirheumatic drug for the treatment of rheumatoid arthritis. Scand J Rheumatol 23 [Suppl 100]:31-44
5. 2 blocking drugs. Neurobiol Aging 16:523-530
6. Cadman ED, Witte DG, Lee CM (1994) Regulation of the release of interleukin-6 from human astrocytoma cells. J Neurochem 63:980-987
7. Camphell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MB, Mucke L (1993) Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci USA 90:10061-10065
8. Conti P, Reale M, Barbacane RC, Stuard S, Placido F (1994) Effect of the antirheumatic agent tenidap on CD3, CD4, and CD8 expression and interleukin-1 and leukotriene B4 secretion in human peripheral blood mononuclear cells. Biochem Cell Biol 72:397-402
9. Fiebich BL, Lieb K, Berger M, Bauer J (1995) Stimulation of the sphingomyelin pathway induces interleukin-6 gene expression in human astrocytoma cells. J Neuroimmunol 63:207-211
10. 2b receptors mediate an increase in interleukin (IL)-6 mRNA and IL-6 protein synthesis in human astroglioma cells. J Neurochem 66:1426-1431
11. Fiebich BL, Lieb K, Huell M, Berger M, Bauer J (1996b) Effects of NSAIDs on IL-1β-induced IL-6 mRNA and protein synthesis in human astrocytoma cells. Neuroreport 7:1209-1213
12. Fiebich BL, Huell M, Lieb K, Gyufko K, Berger M, Bauer J (1996c) Prostaglandin E2 induces IL-6 synthesis in human astrocytoma cells. J Neurochem (in press)
13. Golding S, Emery P, Young SP (1995) Tenidap-modulated proinflammatory cytokine activation of a monocyte cell line. J Immunol 154:5384-5390
14. Griffin WST, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL, Araoz C (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer's disease. Proc Natl Acad Sci USA 86:7611-7615
15. Griffin WST, Sheng JG, Roberts GW, Mrak RE (1995) Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J Neuropathol Exp Neurol 54:276-281
16. Huell M, Strauss S, Volk B, Berger M, Bauer J (1995) Interleukin-6 is present in early stages of plaque formation and is restricted to brains of Alzheimer's disease patients. Acta Neuropathol (Berl) 89:544-551
17. Laliberte R, Perregaux D, Svensson L, Pazoles CJ, Gabel CA (1994) Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro. II. Inhibition of IL-1 beta production from ATP-treated monocytes and macrophages. J Immunol 153:2168-2179
18. Lieb K, Fiebich BL, Busse-Grawitz M, Huell M, Berger M, Bauer J (1996a) Effects of substance P and selected other neuropeptides on the synthesis of interleukin-1β and interleukin-6 in human monocytes: a reexamination. J Neuroimmunol 67:77-81
19. Lieb K, Kaltschmidt C, Kaltschmidt K, Baeuerle PA, Berger M, Bauer J, Fiebich BL (1996b) Interleukin-1β uses common and distinct signaling pathways for induction of the interleukin-6 and tumor necrosis factor a genes in the human astrocytoma cell line U373. J Neurochem 66:1496-1503
20. Loose LD, Sipe JD, Kirby DS, Kraska AR, Weiner ES, Shanahan WR, Leeming MR, Farrow P, Stack CB, Ting N (1993) Reduction of acute-phase proteins with tenidap sodium, a cytokine-modulating anti-rheumatic drug. Br J Rheumatol 32 [Suppl 3]:19-25
21. Madhok R (1995) Tenidap. Lancet 346:481-485
22. Moore PF, Larson DL, Otterness IG, Weissman A, Kadin SB, Sweeney FJ, Eskra JD, Nagahisa A, Sakakibara M, Carty TJ (1996) Tenidap, a structurally novel drug for the treatment of arthritis: antiinflammatory and analgesic properties. Inflamm Res 45:54-61
23. Norris JG, Tang LP, Sparacio SM, Benveniste EN (1994) Signal transduction pathways mediating astrocyte IL-6 induction by IL-1 beta and tumor necrosis factor-alpha. J Immunol 152:841-850
24. Otterness IG, Bliven ML, Downs JT, Natoli EJ, Hanson DC (1991) Inhibition of interleukin 1 synthesis by tenidap: a new drug for arthritis. Cytokine 3:277-283
25. Panés J, Russell JM, Wolf RE, Wallace JL, Granger DN (1995) Effects of tenidap on leukocyte-endothelial cell adhesion in mesenteric venules. J Rheumatol 22:444-449
26. Pelletier JP, McCollum R, DiBattista J, Loose LD, Cloutier JM, Martel-Pelletier J (1993) Regulation of human normal and osteoarthritic chondrocyte interleukin-1 receptor by antirheumatic drugs. Arthritis Rheum 36:1517-1527
27. Ramamurthy N, Greenwald R, Moak S, Scuibba J, Goren A, Turner G, Rifkin B, Golub L (1994) CMT/tenidap treatment inhibits temporomandibular joint destruction in adjuvant arthritic rats. Ann N Y Acad Sci 732:427-430
28. Rich J, Rasmusson DX, Folstein MF, Carson KA, Kawas C, Brandt J (1995) Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 45:51-55
29. Rogers J, Kirby LC, Hempelman SR, Berry DL, McGeer PL, Kaszniak AW, Zalinski J, Cofield M, Mansukhani L, Wilson P (1993) Clinical trial of indomethacin in Alzheimer's disease. Neurology 43:1609-1611
30. Sipe JD, Bartle LM, Loose LD (1992) Modification of proinflammatory cytokine production by the antirheumatic agents tenidap and naproxen. A possible correlate with clinical acute phase response. J Immunol 148:480-484
31. Sparacio SM, Zhang Y, Vilcek J, Benveniste EN (1992) Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-kappa B-like nuclear protein. J Neuroimmunol 39:231-242
32. Wood JA, Wood PL, Ryan R, Graff Radford NR, Pilapil C, Robitaille Y, Quirion R (1993) Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein. Brain Res 629:245-252